i3 Consult Press Releases

Prior to launching the marketing campaign for your newly licensed NCE, it is imperative to conduct team interviews to identify the target audience, knowledge gaps and blind spots from historical marketing campaigns. These interviews could be one-on-one structured or semi-structured conversations. Extended interviewing of consensually selected healthcare payer industry experts with adapted questions could also be performed for refinement and reflection of the internal findings. Focus groups/structured meetings consisting of 5 to 10 team members each from a different target market segment or a cross-section of a value chain could also be  conducted to brainstorm a storyline and develop content. As a further refinement strategy, surveys of closed research instrument design will test attitudes and perceptions on both the current pharma product offerings and clearly defined future ones to a selected pool of healthcare payers. The objective here is to check on congruency of the story develop

Pharmaceutical repackaging has become a growth market amidst an increasingly patient-centric healthcare market for a number of reasons: to fit with the dosage and formulation needs of different patient groups; to reduce treatment administration errors associated with doses in liquid form at the point of patient care; to eliminate residual quantities of addictive prescription medicines; to improve patient compliance by resizing or reformulating in more convenient dosages; or for improved convenience to the healthcare practitioner by changing the method of administering to a patient; and lastly but certainly not the least is the  importance of reducing cost. In some cases, however, the market opportunities for repackaging are less clear. By conducting interviews and online surveys with the 4Ps (Patients, Providers – Drs., nurses etc., Payors – health insurance providers and Pharma – supplier of primary packaging material) of the healthcare sector, i3 Consult can achieve a 360 o perspe

i3 Consult Case Study: Structure, Function, Roles and Responsibilities for a Small Cap Medical Device Company The Challenges: For a fast-growing medical device company having a global presence, there are challenges both internal and external to the organization. Being responsive to the regulatory, quality and safety issues, across multiple global markets can be overwhelming to the executives of a small cap medical device company. Internally medical device company executives are held accountable to reach certain milestones set by Director of the Board (e.g. study completion, licensing approval in key markets, publication of proof of concept data, sales turnover targets, to name just a few) and/or are tasked to deal with company-wide issues which may be either technical, regulatory, or business related. Outsourcing to a consultant with vertical knowledge in a specific functional area is a standard approach in systematically trying to meet the milestones set or deal with the issues f